Publishing schedule 2023:

No. Appears Booking and materials for product ads Booking and materials for recruitment ads Theme
1-2 13.1. 3.1. 10.1. New medicine and innovations, Recruiting
3 27.1. 17.1. 24.1. Psychiatry
4 3.2. 24.1. 31.1. Asthma
5 10.2. 31.1. 7.2. Cardiovascular diseases
6-7 17.2. 7.2. 14.2. Rare diseases
8 3.3. 21.2. 28.2. Neurology
9 10.3. 28.2. 7.3. Diabetes
10 17.3. 7.3. 14.3. Allergy
11 24.3. 14.3. 21.3. Autoimmune diseases
12-13 31.3. 21.3. 28.3. Vaccines
14 14.4. 4.4. 11.4. Skin diseases
15 21.4. 11.4. 18.4. Cancer and blood diseases
16-17 28.4. 18.4. 25.4. Intestinal diseases
18 12.5. 2.5. 9.5. Diabetes
19 19.5. 9.5. 15.5. Neurology
20 26.5. 16.5. 23.5. Gynecology
21 2.6. 23.5. 30.5. Infections
22 9.6. 30.5. 6.6. Lung diseases
23-24 16.6. 6.6. 13.6. Cancer and blood diseases
25 11.8. 1.8. 8.8. New medicine and innovations
26 18.8. 8.8. 15.8. Health technology, Recruitment
27 25.8. 15.8. 22.8. Depression
28 1.9. 22.8. 29.8. Asthma
29 8.9. 29.8. 5.9. Infections
30 15.9. 5.9. 12.9. Neurology
31 22.9. 12.9. 19.9. Lung diseases
32 29.9. 19.9. 26.9. Vaccines
33 6.10. 26.9. 3.10. Rheumatic
34 13.10. 3.10. 10.10. Intestinal diseases
35-36 20.10. 10.10. 17.10. Pain and migraine
37 3.11. 24.10. 31.1. Schizophrenia
38-39 10.11. 31.10. 7.11. Diabetes
40 24.11. 14.11. 21.11. Cancer and blood diseases
41-42 1.12. 21.11. 28.11. Cardiovascular diseases
43 15.12. 5.12. 12.12. 100 influencers

*Additional pharmacy distribution

 

 

Publishing schedule 2022:

No Issued Booking and materials for product ads Booking and materials for recruitment ads Themes
1-2 7.1. double 28.12. 3.1. New drugs and innovations,
Farmasia’s 1000 pcs additional distribution
3 21.1. 11.1. 18.1. Psychiatry and recruiting
4 28.1. 18.1. 25.1. Asthma
5 4.2. 25.1. 1.2. Cardiovascular diseases,
Farmasia’s 1000 pcs additional distribution, research issue
6 11.2. 1.2. 8.2. Oncology and hematologic diseases
7-8 18.2. double 8.2. 15.2. Neurology
9 4.3. 22.2. 1.3. Autoimmune diseases
10 11.3. 1.3. 8.3. Diabetes
11-12 18.3. 8.3. 15.3. Vaccines,
Farmasia’s 1000 pcs additional distribution
13 1.4. 22.3. 29.3. Allergy
14-15 8.4. double 29.3. 5.4. Dermatology
16 22.4. 8.4. 19.4. Accident and Emergency medicine
17-18 29.4. double 19.4. 26.4. Bowel diseases
19 13.5. 3.5. 10.5. Diabetes,
Farmasia’s 1000 pcs additional distribution
20 20.5. 10.5. 17.5. Neurology and MS disease, research issue
21 27.5. 16.5. 23.5. Gyneacology
22 3.6. 23.5. 31.5. Infections
23 10.6. 31.5. 7.6. Lung diseases
24-25 17.6. double 7.6. 14.6. Oncology and hematologic diseases
26 12.8. 2.8. 9.8. New drugs and innovations,
Farmasia’s 1000 pcs additional distribution
27 19.8. 9.8. 16.8. Health technology
28 26.8. 16.8. 23.8. Depression
29 2.9. 23.8. 30.8. Asthma
30 9.9. 30.8. 6.9. Infections
31-32 16.9. double 6.9. 13.9. Neurology
33 30.9. 20.9. 27.9. Lung diseases, research issue
34 7.10. 27.9. 4.10. Vaccines,
Farmasia’s 1000 pcs additional distribution
35-36 14.10. double 4.10. 11.10. Rheumatic diseases
37 28.10. 18.10. 25.10. Bowel diseases
38 4.11. 25.10. 1.11. Diabetes
39 11.11. 1.11. 8.11. Schizophrenia
40 18.11. 8.11. 15.11. Pain and migraine,
Farmasia’s 1000 pcs additional distribution
41 25.11. 15.11. 22.11. Oncology and hematologic diseases, research issue
42 2.12. 22.11. 29.11. Cardiovascular diseases
43-44 9.12. double 28.11. 5.12. 100 influencers,
Farmasia’s 1000 pcs additional distribution